Search

Author/Creator Park, Se Hoon

1. 345 Phase 3 study of combination pembrolizumab + olaparib therapy versus enzalutamide/abiraterone in metastatic castration-resistant prostate cancer (mCRPC) after progression on chemotherapy (KEYLYNK-010). (10th December 2020)

Authors:
Yu, Evan; Park, Se Hoon; Huang, Yi-Hsiu; Bennamoun, Mostefa; Xu, Lu; Kim, Jeri; Antonarakis, Emmanuel
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A210
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 345 Phase 3 study of combination pembrolizumab + olaparib therapy versus enzalutamide/abiraterone in metastatic castration-resistant prostate cancer (mCRPC) after progression on chemotherapy (KEYLYNK-010). (9th November 2020)

Authors:
Yu, Evan; Park, Se Hoon; Huang, Yi-Hsiu; Bennamoun, Mostefa; Xu, Lu; Kim, Jeri; Antonarakis, Emmanuel
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A370
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer. Issue 3 (May 2017)

Authors:
Hwang, In Gyu; Ji, Jun Ho; Kang, Jung Hun; Lee, Hyo Rak; Lee, Hui-Young; Chi, Kyong-Choun; Park, Suk Won; Lee, Su Jin; Kim, Seung Tae; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki
Journal:
Journal of geriatric oncology
Issue:
Volume 8:Issue 3(2017)
Page Start:
170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10236 (16th May 2020)

Authors:
Galsky, Matthew D; Arija, José Ángel Arranz; Bamias, Aristotelis; Davis, Ian D; De Santis, Maria; Kikuchi, Eiji; Garcia-del-Muro, Xavier; De Giorgi, Ugo; Mencinger, Marina; Izumi, Kouji; Panni, Stefano; Gumus, Mahmut; Özgüroğlu, Mustafa; Kalebasty, Arash Rezazadeh; Park, Se Hoon; Alekseev, Boris;...
Journal:
Lancet
Issue:
Volume 395:Issue 10236(2020)
Page Start:
1547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Bridging genomics and phenomics of gastric carcinoma. Issue 9 (18th March 2019)

Authors:
Cho, Junhun; Ahn, Soomin; Son, Dae‐Soon; Kim, Nayoung KD; Lee, Ki‐Wook; Kim, Seungtae; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Kang, Won Ki; An, Ji Yeong; Choi, Min Gew; Lee, Jun‐Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung; Kim, Kyoung‐Mee
Journal:
International journal of cancer
Issue:
Volume 145:Issue 9(2019)
Page Start:
2407
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment. (November 2020)

Authors:
Lee, Min-Sang; Cho, Hee Jin; Hong, Jung Yong; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki; Cho, Yong Beom; Kim, Seung Tae
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Clinical Application of Targeted Deep Sequencing in Solid‐Cancer Patients and Utility for Biomarker‐Selected Clinical Trials. (12th July 2017)

Authors:
Kim, Seung Tae; Kim, Kyoung‐Mee; Kim, Nayoung K.D.; Park, Joon Oh; Ahn, Soomin; Yun, Jae‐Won; Kim, Kyu‐Tae; Park, Se Hoon; Park, Peter J.; Kim, Hee Cheol; Sohn, Tae Sung; Choi, Dong Il; Cho, Jong Ho; Heo, Jin Seok; Kwon, Wooil; Lee, Hyuk; Min, Byung‐Hoon; Hong, Sung No; Park, Young Suk; Lim, Ho Y...
Journal:
Oncologist
Issue:
Volume 22:Number 10(2017)
Page Start:
1169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗